Can I switch from Wegovy to compounded semaglutide without restarting?

Typically yes — a prescriber maps your current dose across as a continuation; confirm dose continuity in writing with the new program.

What do I give up switching from Wegovy?

FDA approval, brand manufacturing, and the trial certificates — the honest cost of the $380/month savings.

Should I switch if insurance covers Wegovy?

Almost never — covered brand copays (~$25-class) beat the compounded cash lane.

Quick answer · /answers/ cluster · Transition mechanics

Can I switch from Wegovy to compounded semaglutide?

QUICK ANSWER FILEUpdated August 17, 2026

THE SHORT ANSWER

Mechanically, yes — with a prescriber managing the handoff. Same intended active ingredient means the transition is typically a continuation, not a restart: your current dose maps across, and semaglutide’s ~7-day half-life makes ordinary transfer gaps forgiving. The real work is administrative and honest: a new patient-specific prescription, pharmacy verification, records transfer (owed to you within 30 days), and eyes-open acknowledgment that you’re moving from the FDA-approved product to a non-approved compounded version — usually for the $380/month gap between $499 cash and the $119 audited floor. Reverse switches (compounded → brand) run the same mechanics toward the certificates.

Before switching, run the two checks that outrank the savings: coverage (if Wegovy is covered, ~$25-class copays beat the cash math entirely) and continuity in writing — the new program confirming your current dose, not restarting titration. The full playbook, both directions: the switch guide; the destination priced: the current floor.